Yigal Nochomovitz
Stock Analyst at Citigroup
(2.30)
# 2,414
Out of 4,791 analysts
294
Total ratings
37.34%
Success rate
-1.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $20.46 | +71.07% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $25.51 | +84.24% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $11.92 | +59.40% | 16 | Mar 7, 2025 | |
| ARVN Arvinas | Maintains: Neutral | $28 → $19 | $7.18 | +164.62% | 9 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $18.21 | +202.03% | 11 | Mar 6, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $45 → $42 | $12.97 | +223.82% | 8 | Mar 4, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $206 → $215 | $181.00 | +18.78% | 4 | Feb 20, 2025 | |
| CADL Candel Therapeutics | Initiates: Buy | $25 | $5.31 | +370.81% | 1 | Feb 20, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $89 → $82 | $34.19 | +139.84% | 21 | Feb 18, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $33 | $5.37 | +514.53% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $43.01 | +125.53% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.44 | +1,714.06% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $0.86 | +596.86% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $51 | $23.00 | +121.74% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.88 | +104.92% | 14 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $8.43 | +220.28% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.98 | +103.33% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $18.00 | +100.00% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $16.35 | +254.74% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $2.16 | +918.52% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.22 | +1,047.54% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.34 | +252.94% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $7.89 | +381.62% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $5.78 | +142.21% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.37 | +45.99% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $36.43 | +81.17% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $10.20 | +370.59% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.33 | +500.60% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.33 | +50.23% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $1.93 | -48.19% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $6.13 | +470.96% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $35.37 | +276.02% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.50 | +1,490.14% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $1.06 | +466.04% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.26 | +1,169.84% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.77 | +1,198.70% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.84 | +1,805.44% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.79 | +570.39% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.01 | - | 14 | Sep 28, 2021 |
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $20.46
Upside: +71.07%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $25.51
Upside: +84.24%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $11.92
Upside: +59.40%
Arvinas
Mar 7, 2025
Maintains: Neutral
Price Target: $28 → $19
Current: $7.18
Upside: +164.62%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $18.21
Upside: +202.03%
Syndax Pharmaceuticals
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $12.97
Upside: +223.82%
Krystal Biotech
Feb 20, 2025
Maintains: Neutral
Price Target: $206 → $215
Current: $181.00
Upside: +18.78%
Candel Therapeutics
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.31
Upside: +370.81%
CRISPR Therapeutics AG
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $34.19
Upside: +139.84%
EyePoint Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $5.37
Upside: +514.53%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $43.01
Upside: +125.53%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.44
Upside: +1,714.06%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $0.86
Upside: +596.86%
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $23.00
Upside: +121.74%
Nov 4, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $4.88
Upside: +104.92%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $8.43
Upside: +220.28%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.98
Upside: +103.33%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $18.00
Upside: +100.00%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $16.35
Upside: +254.74%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $2.16
Upside: +918.52%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.22
Upside: +1,047.54%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.34
Upside: +252.94%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $7.89
Upside: +381.62%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $5.78
Upside: +142.21%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.37
Upside: +45.99%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $36.43
Upside: +81.17%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $10.20
Upside: +370.59%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $3.33
Upside: +500.60%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.33
Upside: +50.23%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $1.93
Upside: -48.19%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $6.13
Upside: +470.96%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $35.37
Upside: +276.02%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.50
Upside: +1,490.14%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $1.06
Upside: +466.04%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.26
Upside: +1,169.84%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $0.77
Upside: +1,198.70%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $0.84
Upside: +1,805.44%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.79
Upside: +570.39%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $3.01
Upside: -